- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
Valisure CEO Shares Thoughts on Johnson & Johnson Sunscreen Recall
Author(s):
In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again.
Video Player is loading.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
The Future of laBCC Treatment with Vishal Patel, MD, FAAD, FACMS
Apoptosis-Based Skin Cancer Treatment Shows Promise
Mastering Dermoscopy and Dysplastic Nevi
The Future of AI in Dermatology with Andy Beck, MD, PhD
How PathAI’s PathAssist Derm Tool Aims to Enhance Skin Cancer Diagnosis and Workflow Efficiency
Expanding Collaborations in the Fight Against Skin Cancer
Spearheading Awareness Campaigns for Skin Cancer Prevention and Sun Protection
Resources for Patients and Clinicians from the Skin Cancer Foundation
2025 Goals and Priorities of The Skin Cancer Foundation: An Interview with Executive Director, Becky Kamowitz
Data Review of 2 doses of Sonidegib in Advanced Basal Cell Carcinoma (BOLT Trial)
Related Content
